thumbnail_Pan-Biome-logo.png
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
February 24, 2021 10:00 ET | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
Kyo-Dophilus Probiotics For Every Life Stage
June 12, 2019 08:54 ET | Wakunaga of America: Kyo-Dophilus Probiotics
MISSION VIEJO, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Researchers are continuing to discover that blood pressure, cognitive function and even a person’s mood may be highly influenced by the...
LeadingLogo.png
Leading BioSciences to Present at Planet MicroCap Showcase 2019
April 25, 2019 08:05 ET | Leading BioSciences
CARLSBAD, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
June 19, 2018 07:05 ET | Leading BioSciences
CARLSBAD, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- Leading BioSciences, a drug development company focused on improving human health through therapeutic protection of the Gastrobiome™, today...
The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market
May 17, 2016 11:20 ET | Insight Pharma Reports
NEEDHAM, MA--(Marketwired - May 17, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, offers additional coverages on the human microbiome with a second report, "The Human...
Newest Data on the Human Microbiome and Its Growth Into the Commercial Market
May 10, 2016 13:30 ET | Insight Pharma Reports
NEEDHAM, MA--(Marketwired - May 10, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, offers a series of market data on the human microbiome in the form of two life science...